STS-1 Antibodies

Santa Cruz Biotechnology offers a broad range of STS-1 monoclonal antibodies for research applications. STS-1 monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). STS-1, or Suppressor of Tumorigenicity 1, plays a critical role in cellular processes such as cell growth, differentiation, and apoptosis. Research has shown that STS-1 significantly influences tumor suppression and regulates oncogenic pathways. Understanding STS-1 function continues to be a key focus in cancer research and therapeutic development. STS-1 monoclonal antibodies enable precise detection and analysis of protein expression patterns across various experimental conditions. Researchers can utilize STS-1 monoclonal antibodies to explore protein interactions and signaling mechanisms in both normal and pathological states. Current investigations with STS-1 monoclonal antibodies are advancing our understanding of cancer biology and contributing to the development of targeted therapeutic strategies. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in their mission to unlock new insights in cancer research and therapeutic development.